Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
clinical trials
7
×
life sciences
national blog main
san francisco blog main
7
×
national top stories
san francisco top stories
cancer
cancer drugs
fda
biotech ipos
deals
investing
new york blog main
new york top stories
abbvie
alzheimer's disease
boston
cancer immunotherapy
eli lilly
europe blog main
european society for medical oncology
ipo
medicare
mirati therapeutics
national
nonalcoholic steatohepatitis
revolution medicines
san francisco
sanofi
the column group
third rock ventures
warp drive bio
89bio
acute myeloid leukemia
adrian krainer
alexion pharmaceuticals
aligos therapeutics
What
research
7
×
medicines
biotech
ipo
cancer
drug
companies
ipos
new
proteins
revolution
targets
way
week
abbvie
alliance
alzheimer’s
annual
arrival
assessed
attention
bio
biotechs
black
cancer’s
central
clinic
cns
communities
conference
days
despite
diamond
disease
disorder
drugs
editas
editing
eluded
emerged
Language
unset
Current search:
" clinical trials "
×
" san francisco blog main "
×
research
×
@xconomy.com
3 years ago
Praxis Precision Medicines Leads Way as Three More Biotechs Prep IPOs
@xconomy.com
3 years ago
AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
Revolution Medicines Maps Out an IPO to Reach Cancer’s Frontiers
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More